Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
US11034694B2 · kind B2 · utility
11Cited by
12References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2020 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Sep 14, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/07
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula I: or pharmaceutically acceptable salts and/or pharmaceutical compositions thereof. The present invention also provides methods for the inhibition of HPK1 and methods for the treatment of HPK1-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.